Now Is The Season To: April 2011

Published on by on April 1, 2011

Consider High Dividend Paying ETFs

With IRA contribution deadlines fast approaching, many investors look to have a nice pile of cash in their accounts that is ready to be deployed across the market. However, with geopolitical risks spiking, the current market isn’t exactly a friendly place to be leaving many investors to wonder just which sectors are safe. While we here at ETF Database don’t know what will happen, we do know that dividends can help smooth out volatility and can provide solid income even in turbulent markets making high dividend paying funds a great pick in this environment for both IRA-focused investors and long-term buy and holders alike. Below, we highlight four interesting funds that pay out robust dividends and could make for a quality investment for those looking to buy for the long-term.

Pro Membership Required to Continue Reading ETFdb Pro

To continue reading this article, you must be an ETFdb Pro member. Please login or begin your 14-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:
  • Register on ETFdbAccess to 50+ All-ETF model portfolios. Whether you're a long-term, buy-and-hold investor or a more active trader looking to establish a tactical position, our collection of ETFdb Portfolios has something for everyone.
  • ETFdb Realtime Ratings show you exactly where each fund stacks up next to the competition. Get objective, in-depth, custom research on every ETF.
  • Pro members have Unlimited Excel Download capabilities across the entire database; users can easily download more than 200 data filled paged and also export results to Microsoft Excel from every tool.
  • Get ETF Picks of the Month. For active investors seeking ETF investment ideas, our team analyzes technical and fundamental price drivers of more than 1,400 ETFs to identify both short and longer-term opportunities with a focus on absolute returns. Recommendations are actionable investment ideas that are poised for outperformance over the next week to 90 days.

Begin Your Free 14-Day Trial Now